Speakers

ai, analytics, business, business event, cancer, chief data officer, clinical pharmacology, clinical trial, conference, confirmation bias, covid-19 pandemic, data analysis, disease, electronic health record, emerging tech, emerging technologies, entrepreneur conference, ethics, fee-for-service, forecasting, general data protection regulation, governance, gs1, health, health care, health system, information, information technology, insight, machine learning, medication, medicine, ml, nursing, patient participation, pharmacology, pharmacy, point of care, privacy, privacy policy, profit (economics), psychological resilience, quality assurance, risk management, science, simulation, supply chain, therapeutic index, truth, understanding

ai, analytics, business event, cancer, clinical pharmacology, clinical trial, conference, covid-19 pandemic, disease, electronic health record, emerging tech, emerging technologies, entrepreneur conference, fee-for-service, forecasting, gs1, health, health care, health system, machine learning, medication, medicine, ml, patient participation, pharmacology, pharmacy, simulation, supply chain, therapeutic index, understanding

ai, analytics, business event, cancer, clinical pharmacology, clinical trial, conference, covid-19 pandemic, disease, electronic health record, emerging tech, emerging technologies, entrepreneur conference, fee-for-service, forecasting, gs1, health, health care, health system, machine learning, medication, medicine, ml, patient participation, pharmacology, pharmacy, simulation, supply chain, therapeutic index, understanding

akamai technologies, attention, biotechnology, brca mutation, business model, cancer, competitive advantage, content delivery network, international trade, internet, just-in-time manufacturing, license, market (economics), medication, non-tariff barriers to trade, obsolescence, patent, patent application, pharmacology, search engine technology, social media, supply chain

clinical trial, computer, computer science, covid-19, death, disease, drug development, experiment, gene, infection, interactome, learning, machine learning, network medicine, optics, pharmacology, physical attractiveness, prediction, protein production, protein–protein interaction, reason, science, severe acute respiratory syndrome coronavirus 2, structure, virus

marijuana therapeutics and research, adherence (medicine), americans for safe access, asa conference, asa unity, asa unity 2021, cannabis, cannabis conference 2021, chronic pain, clinical trial, dose (biochemistry), drug enforcement administration, drug prohibition law, emergency department, food and drug administration, health care, health economics, international narcotics control board, marijuana, marijuana conference 2021, medical cannabis, medical cannabis education, medicare (united states), medication, obesity, opioid, opioid epidemic, pain, pharmacology, pharmacy, pit bull, prohibition of drugs, substance dependence, tax, unity2021, welfare

allopathic medicine, anesthesiology, asa conference, board certification, budtender, cannabinoid, cannabis (drug), cannabis conference 2021, cannabis washington, d.c., emergency department, emergency medicine, endocannabinoid system, family medicine, general practitioner, health care, internal medicine, medical cannabis, medical cannabis education, medical cannabis industry training, medical director, medical specialty, medicaln marijuana, medicine, mental disorder, neurology, nursing, patients right advocacy, pharmacology, physician, psychiatry, safe access , safeaccess , shame, tetrahydrocannabinol

allopathic medicine, anesthesiology, asa conference, board certification, budtender, cannabinoid, cannabis (drug), cannabis conference 2021, cannabis washington, d.c., emergency department, emergency medicine, endocannabinoid system, family medicine, general practitioner, health care, internal medicine, medical cannabis, medical cannabis education, medical cannabis industry training, medical director, medical specialty, medicaln marijuana, medicine, mental disorder, neurology, nursing, patients right advocacy, pharmacology, physician, psychiatry, safe access , safeaccess , shame, tetrahydrocannabinol

allopathic medicine, anesthesiology, asa conference, board certification, budtender, cannabinoid, cannabis (drug), cannabis conference 2021, cannabis washington, d.c., emergency department, emergency medicine, endocannabinoid system, family medicine, general practitioner, health care, internal medicine, medical cannabis, medical cannabis education, medical cannabis industry training, medical director, medical specialty, medicaln marijuana, medicine, mental disorder, neurology, nursing, patients right advocacy, pharmacology, physician, psychiatry, safe access , safeaccess , shame, tetrahydrocannabinol

allopathic medicine, anesthesiology, asa conference, board certification, budtender, cannabinoid, cannabis (drug), cannabis conference 2021, cannabis washington, d.c., emergency department, emergency medicine, endocannabinoid system, family medicine, general practitioner, health care, internal medicine, medical cannabis, medical cannabis education, medical cannabis industry training, medical director, medical specialty, medicaln marijuana, medicine, mental disorder, neurology, nursing, patients right advocacy, pharmacology, physician, psychiatry, safe access , safeaccess , shame, tetrahydrocannabinol

marijuana therapeutics and research, adherence (medicine), americans for safe access, asa conference, asa unity, asa unity 2021, cannabis, cannabis conference 2021, chronic pain, clinical trial, dose (biochemistry), drug enforcement administration, drug prohibition law, emergency department, food and drug administration, health care, health economics, international narcotics control board, marijuana, marijuana conference 2021, medical cannabis, medical cannabis education, medicare (united states), medication, obesity, opioid, opioid epidemic, pain, pharmacology, pharmacy, pit bull, prohibition of drugs, substance dependence, tax, unity2021, welfare

cannabis company washington, d.c., marijuana therapeutics and research, adherence (medicine), americans for safe access, asa conference, asa unity, asa unity 2021, asus, cannabis, cannabis (drug), cannabis 2021, cannabis conference 2021, cannabis washington, d.c., charlotte figi, chronic pain, clinical trial, community, covid-19 pandemic, dispensary, dose (biochemistry), drug enforcement administration, drug prohibition law, emergency department, food and drug administration, health care, health economics, international narcotics control board, ipod classic, la la land, language, law, legal access to cannabis, legislative advocacy, lgbt community, marijuana, marijuana conference 2021, marijuana policy project, medical cannabis, medical cannabis education, medicaln marijuana, medicare (united states), medication, obesity, opioid, opioid epidemic, organization, pain, pandemic, patient, pharmacology, pharmacy, pit bull, presidency, prohibition of drugs, reggae, rights, san diego, substance dependence, tax, united states, united states congress, unity2021, usb, welfare

5-ht2a receptor, 5-hydroxytryptophan, albert hofmann, amyotrophic lateral sclerosis, benzinga insights, bzcannabis, cannabis conference 2021, cannabis entrepreneurs , cannabis event 2021, cannabis market growth, clinical trial, drug design, drug discovery, economics, fluoxetine, incentive, intellectual property, investor, legal cannabis industry , lysergic acid diethylamide, major depressive disorder, medication, mental health, neuroimaging, pharmaceutical industry, pharmacodynamics, pharmacology, phases of clinical research, psilocybin, serotonin, suicide, trading strategies cannabis, valuation (finance)

5-ht2a receptor, 5-hydroxytryptophan, albert hofmann, amyotrophic lateral sclerosis, benzinga insights, bzcannabis, cannabis conference 2021, cannabis entrepreneurs , cannabis event 2021, cannabis market growth, clinical trial, drug design, drug discovery, economics, fluoxetine, incentive, intellectual property, investor, legal cannabis industry , lysergic acid diethylamide, major depressive disorder, medication, mental health, neuroimaging, pharmaceutical industry, pharmacodynamics, pharmacology, phases of clinical research, psilocybin, serotonin, suicide, trading strategies cannabis, valuation (finance)

attention, composer, cross-validation (statistics), data, evaluation, gas, health informatics, hospital, medication, medicine, montreal, mother, patient, pharmacology, pharmacy, triage, united states

attention, composer, cross-validation (statistics), data, evaluation, gas, health informatics, hospital, medication, medicine, montreal, mother, patient, pharmacology, pharmacy, triage, united states

attention, composer, cross-validation (statistics), data, evaluation, gas, health informatics, hospital, medication, medicine, montreal, mother, patient, pharmacology, pharmacy, triage, united states

3d modeling, accuracy and precision, adverse event, bayesian inference, business model, calibration, clinical pharmacology, data, dose (biochemistry), drug, github, hamiltonian monte carlo, likelihood function, map, mass, mass concentration (astronomy), maximum likelihood estimation, monte carlo method, open source, personalized medicine, pharmacokinetics, pharmacology, prediction, simulation, uncertainty

3d modeling, accuracy and precision, adverse event, bayesian inference, business model, calibration, clinical pharmacology, data, dose (biochemistry), drug, github, hamiltonian monte carlo, likelihood function, map, mass, mass concentration (astronomy), maximum likelihood estimation, monte carlo method, open source, personalized medicine, pharmacokinetics, pharmacology, prediction, simulation, uncertainty

adherence (medicine), adverse effect, analytics, big data, causality, clinical trial, customer relationship management, european medicines agency, food and drug administration, general data protection regulation, html, information sensitivity, machine learning, medical prescription, natural language processing, nlp, oxaprozin, pharmaceutical industry, pharmacology, pharmacovigilance, physician, pronoun, startup company, use case

aspirin, biotechnology, brewery, clinical trial, computer vision, deep learning, docking (molecular), drug discovery, exescale day, health, health care, in vitro, machine learning, mechanism of action, medication, microscopy, natural product, pharmaceutical industry, pharmacodynamics, pharmacology, preventive healthcare, protein, reverse engineering, salicylic acid, thecube, university of mississippi

aspirin, biotechnology, brewery, clinical trial, computer vision, deep learning, docking (molecular), drug discovery, exescale day, health, health care, in vitro, machine learning, mechanism of action, medication, microscopy, natural product, pharmaceutical industry, pharmacodynamics, pharmacology, preventive healthcare, protein, reverse engineering, salicylic acid, thecube, university of mississippi

ai, analogy, aspirin, automotive industry in germany, biodiversity, biologist, biotechnology, blockchain, bmw, brain, breathalyzer, brewery, car, clinical trial, computer vision, consciousness, coronavirus disease 2019, ct scan, decision-making, deep learning, disease, docking (molecular), drug discovery, electric vehicle, emerging technologies, emotion, employment, engineering, evolution, exescale day, gene expression, germany, health, health care, hope, hospitals ai, human, in vitro, infection, intelligence, leukemia, machine learning, magnetic resonance imaging, mathematical optimization, mechanism of action, medical imaging, medication, medicine, microscopy, microservices, natural product, nursing, pharmaceutical industry, pharmacodynamics, pharmacology, precision medicine, preventive healthcare, privacy, protein, reason, research, reverse engineering, salicylic acid, science, sleep, spock, swarm learning, teaching hospital, technology, thecube, university of mississippi, x-ray

aspirin, biotechnology, brewery, clinical trial, computer vision, deep learning, docking (molecular), drug discovery, exescale day, health, health care, in vitro, machine learning, mechanism of action, medication, microscopy, natural product, pharmaceutical industry, pharmacodynamics, pharmacology, preventive healthcare, protein, reverse engineering, salicylic acid, thecube, university of mississippi

adjuvant therapy, adverse effect, autism, cannabidiol, cannabinoid, cannabis (drug), cannabis edible, caregiver, chemotherapy-induced nausea and vomiting, chronic fatigue syndrome, doctor of osteopathic medicine, dose (biochemistry), drug, drug enforcement administration, epilepsy, expanded access, family medicine, fibromyalgia, gateway drug effect, health, health care, medical cannabis, medical prescription, medication, medicine, mental health, national health service, neurology, nursing, osteopathic medicine in the united states, personalized medicine, pharmacology, pharmacy, physician, prescription drug, psychosis, pulmonary fibrosis, residency (medicine), self-medication, symptom, tetrahydrocannabinol, therapy

adverse effect, bioavailability, cannabidiol, cannabinoid, cannabinoid receptor type 1, cannabinoid receptor type 2, cannabis, clinical trial, cocaine, dose (biochemistry), drug discovery, first pass effect, homeostasis, in vitro, medication, nervous system, neuron, omega-6 fatty acid, pain management, pharmacodynamics, pharmacokinetics, pharmacology, tetrahydrocannabinol, toxicology

attention, biomarker, computer science, data analysis, decision-making, drug development, electrical engineering, engineering, exploratory data analysis, feedback, hypothesis, landing page, linear regression, massachusetts institute of technology, novartis, null hypothesis, p-value, pharmacology, r (programming language), reason, regression analysis, resampling (statistics), statistics, synthetic data, world wide web

attention, biomarker, computer science, data analysis, decision-making, drug development, electrical engineering, engineering, exploratory data analysis, feedback, hypothesis, landing page, linear regression, massachusetts institute of technology, novartis, null hypothesis, p-value, pharmacology, r (programming language), reason, regression analysis, resampling (statistics), statistics, synthetic data, world wide web

attention, biomarker, computer science, data analysis, decision-making, drug development, electrical engineering, engineering, exploratory data analysis, feedback, hypothesis, landing page, linear regression, massachusetts institute of technology, novartis, null hypothesis, p-value, pharmacology, r (programming language), reason, regression analysis, resampling (statistics), statistics, synthetic data, world wide web

attention, biomarker, computer science, data analysis, decision-making, drug development, electrical engineering, engineering, exploratory data analysis, feedback, hypothesis, landing page, linear regression, massachusetts institute of technology, novartis, null hypothesis, p-value, pharmacology, r (programming language), reason, regression analysis, resampling (statistics), statistics, synthetic data, world wide web